v3.26.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Liabilities Measured on Recurring Basis
The following tables present the Company's financial assets and liabilities that are measured at estimated fair value on a recurring basis as of September 30, 2026, and December 31, 2025:
Fair value measurements as of September 30, 2026
(in thousands)
Carrying valueLevel 1Level 2Level 3
Financial assets:
Cash equivalents:
Money market funds9,758 9,758 — — 
Total$9,758 $9,758 $— $— 
Liabilities:
Contingent consideration710 — — 710 
Derivative liability3,224 — — 3,224 
Total
$3,934 $— $— $3,934 
Fair value measurements as of December 31, 2025
(in thousands)
Carrying valueLevel 1Level 2Level 3
Financial assets:
Cash equivalents:
Money market funds161 161 — — 
Total161 161 — — 
Available-for-sale marketable securities:
U.S. government agencies securities1,018 — 1,018 — 
Total1,018 — 1,018 — 
Total$1,179 $161 $1,018 $— 
Liabilities:
Contingent consideration1,741 — — 1,741 
Total
$1,741 $— $— $1,741 
The following table provides a roll-forward of the derivative liability measured at fair value on a recurring basis using unobservable level 3 inputs for the period ended September 30, 2026, as follows:
Fair value at issuance3,205 
Change in fair value19 
Fair value as of September 30, 2026$3,224 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following is a reconciliation of changes in the liability related to contingent consideration during the nine months ended September 30, 2026 and the year ended December 31, 2025 (in thousands):
Fair value as of January 1, 2025
$11 
Change in fair value94 
Earn-out payments in cash(46)
Acquisition1,682 
Fair value as of December 31, 2025
$1,741 
Change in fair value204 
Earn-out payments in cash(104)
Earn-out payments in shares of common stock(1,131)
Fair value as of September 30, 2026$710